Biotricity Return On Tangible Equity 2015-2024 | BTCY

Biotricity return on tangible equity from 2015 to 2024. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.

Biotricity Return On Tangible Equity 2015-2024 | BTCY

Biotricity return on tangible equity from 2015 to 2024. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Related Stocks
Company NameMarket
Cap
Tempus AI (TEM)$10.5B
Hims & Hers Health (HIMS)$5.7B
Inspire Medical Systems (INSP)$5.7B
Axonics (AXNX)$3.6B
IRhythm Technologies (IRTC)$2.7B
Privia Health (PRVA)$2.7B
Enovis (ENOV)$2.6B
Omnicell (OMCL)$2.3B
Azenta (AZTA)$2.2B
10x Genomics (TXG)$1.9B
Schrodinger (SDGR)$1.6B
Clover Health Investments (CLOV)$1.6B
Phreesia (PHR)$1.2B
Standard BioTools (LAB)$763M
Fulgent Genetics (FLGT)$586M
Butterfly Network (BFLY)$571M
Talkspace (TALK)$569M
Definitive Healthcare (DH)$528M
Health Catalyst (HCAT)$495M
Pulmonx (LUNG)$278M
SOPHiA GENETICS SA (SOPH)$261M
TruBridge (TBRG)$234M
P3 Health Partners (PIII)$140M
American Well (AMWL)$136M
EUDA Health Holdings (EUDA)$98M
Future Health ESG (FHLT)$65M
HeartBeam (BEAT)$63M
111 (YI)$56M
CareCloud (CCLD)$51M
Zepp Health (ZEPP)$49M